The Value of 18F-FES-PET/CT in Predicting Fulvestrant Efficacy in Breast Cancer
NCT03768479
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
68
Enrollment
OTHER
Sponsor class
Conditions
Estrogen Receptor-positive Breast Cancer
Fulvestrant
Interventions
DEVICE:
18F-FES-PET
Sponsor
First Affiliated Hospital Xi'an Jiaotong University